Intracranial hypertension is a common occurrence in patients in a severe TBI-induced coma. It is a widespread misconception that ICP will always be low after evacuation of a large intracranial hematoma. Intracranial hypertension has been reported in more than 50% of patients with severe TBI in whom an intracranial mass is evacuated. 17 Postoperative intracranial hypertension may be caused by diffuse cerebral edema, progressive enlargement and swelling of focal contusions, postoperative hematomas at the operative site or at new sites, or various systemic complications. The incidence of intracranial hypertension is greater after evacuation of an intracerebral hematoma than a subdural or epidural hematoma: 71 compared with 39%, respectively. 17 The incidence of elevated ICP during hospitalization in patients without mass lesions has been reported to range from 30 17 to as high as 80% 2 in certain subpopulations. The association between the severity of intracranial hypertension and poor outcome after severe head injury is well recognized. In one series, 77% of patients with an ICP below 15 mm Hg experienced a favorable outcome, whereas only 43% of patients with an ICP above 15 mm Hg experienced a favorable outcome. 14 Miller, et al., 18 reported that the mortality rate increased from 18 to 92% and that the frequency of good outcomes decreased from 74 to 3% when cases of normal ICP were compared with those of intracranial hypertension in which the level could not be decreased to 20 mm Hg. Similarly, Saul and Ducker 26 reported a 69% mortality rate in patients with an ICP greater than 25 mm Hg compared with that of 15% in those in whom the ICP remained less than 25 mm Hg.
The relationship between elevated ICP and a poor outcome is not simply a reflection of the severity of the initial neurological injury. Severe intracranial hypertension can result in secondary cerebral injury by causing ischemia due to reduced CPP. Elevated ICP can also produce distortion and compression of the brainstem. Although no randomized clinical trial has been conducted to address this question, the authors of several clinical series have suggested that reduction of ICP to below 15 to 25 mm Hg reduces the mortality rate after severe head injury. 14, 17, 26 Most authorities currently recommend 20 mm Hg as the threshold above which treatment should generally be initiated.
Detection of Intracranial Hypertension
Intracranial pressure cannot be reliably estimated by observing any clinical feature after severe TBI. Clinical symptoms of raised ICP, such as headache, nausea, and vomiting, are impossible to determine in comatose patients. Papilledema is uncommon after head injury, even in patients with intracranial hypertension. In one study, papilledema was seen in only 3.5% of 426 patients with severe TBI in whom the frequency of elevated ICP exceeded 50%. 28 Additionally, neurological signs that sometimes indicate the presence of elevated ICP, including pupillary dilation and decerebrate posturing, can occur in the absence of intracranial hypertension. Computerized tomography scanning-documented signs of brain swelling, such as midline shift and basal cistern compression, are consistent with raised ICP, but intracranial hypertension can occur in the absence of these findings.
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Posttraumatic Cerebral Ischemia: Scope of the Problem
The injured brain is exceptionally vulnerable to secondary ischemic insults, particularly hypotension and hypoxia, and the occurrence of secondary insults is associated with a poor neurological outcome after severe TBI. 4, 21 Several factors may contribute to posttraumatic cerebral ischemia, including systemic arterial hypotension, increased ICP, cerebral edema, focal tissue compression from hematomas, and microvascular disease. 6, 8, 13, 19, 22, 27 Cerebral Blood Flow-Targeted Therapy Our group conducted a randomized clinical trial to evaluate a treatment strategy designed to maintain adequate CBF and to prevent secondary ischemic insults by maintaining a CPP of at least 70 mm Hg and by avoiding treatments such as hyperventilation, which reduces CBF. 24 This "CBF-targeted" treatment successfully reduced the incidence of jugular venous desaturation, the number of episodes of jugular venous desaturation, and the total duration of time that the SjvO 2 was less than the critical threshold of 50%. The observed reduction in jugular venous desaturations was associated with reductions in systemic hypotension and in hypocarbia. Even with adjustment for all demographic and injury severity-related variables that were significant, the risk of jugular venous desaturation remained 2.36-fold higher in the ICP-targeted treatment group. The CBF-targeted treatment strategy, however, increased the incidence of adult respiratory distress syndrome fivefold and failed to improve long-term neurological outcome. One interpretation of this study is that the beneficial effect of the CBF-targeted treatment was offset by systemic complications associated with maintaining blood pressure at an elevated level.
Variability of Posttraumatic CBF Over Time
Many investigators who have studied post-TBI CBF have emphasized various patterns of changes in CBF. In a few studies investigators have used serial measurements of CBF to examine closely the evolution of TBI over time. 15, 23 Martin, et al., 15 described a phasic pattern of cerebral hemodynamic changes in 125 severely head-injured patients in whom the Glasgow Coma Scale score was lower than 9; the prospective study of these patients involved obtaining intravenous 133 Xe-CBF measurements and cerebral metabolic and/or transcranial Doppler bloodflow velocities. An early hypoperfusion phase during the first 24 hours postinjury was characterized by a low CBF and normal MCA flow velocity. This was followed by a hyperemic phase between postinjury Days 1 and 3 during which CBF was normal or increased, with a rising MCA flow velocity and increasing hemispheric index. Later (postinjury Days 4-15), a period of vasospasm was demonstrated. This phase was associated with a low-normal CBF, high MCA flow velocity, and elevated hemispheric index. Bouma, et al., 1 reported global or rCBF values less than or equal to 18 ml/100 g/min in 31% of head-injured patients when the CBF evaluations were performed a mean of 3.1 hours postinjury, suggesting that most of the severe posttraumatic cerebral ischemia occurs very early after injury.
Variability of Posttraumatic CBF by Region
The same CBF patterns that have been described primarily with global CBF measurements can also occur regionally. In particular, hypoperfusion can occur in brain surrounding a focal contusion or underlying a subdural hematoma. Schroder, et al., 27 observed mean rCBF values of 17.5 ml/100 g/min in pericontusional brain. McLaughlin and Marion 16 observed that CBF values within contused brain and in pericontusional brain were significantly lower than those in the surrounding brain. Focal hyperemia has been observed in 38% of patients, particularly in tissue adjacent to intraparenchymal or extracerebral focal lesions. 25 
Detection of Cerebral Ischemia
As with intracranial hypertension, no reliable clinical findings indicate the presence of cerebral ischemia. The neurological signs caused by brain injury usually obscure any focal findings that might be caused by secondary ischemia. Therefore, cerebral perfusion must be monitored to detect secondary cerebral ischemia after TBI.
The ideal monitoring technique for cerebral ischemia after TBI does not exist. This ideal monitor would give regional information about CBF because there can be marked posttraumatic regional differences in CBF. This ideal monitor would also provide continuous information because CBF evolves over time after injury. The available techniques fall under two general categories: those that monitor cerebral perfusion or blood flow and those that monitor CBF adequacy.
Techniques Based on Perfusion. The simplest measure of cerebral perfusion is the CPP. The CPP can be reduced by either decreases in blood pressure or increases in ICP. For equivalent levels of CPP, cerebral perfusion is impaired more by reductions in blood pressure than by increases in ICP. 20 The CPP has at least two important physiological roles in the patient who has suffered a severe head injury. First, because CPP represents the pressure gradient acting across the cerebrovascular bed, it is an important factor in the regulation of CBF. Second, because CPP contributes to the hydrostatic pressure within the intracerebral vessels, it represents one of the factors that determine edema formation in the injured brain.
Techniques Based on Adequacy of Flow. Measures of cerebral oxygenation, such as SjvO 2 or brain tissue PO 2 , have been used in place of quantitative CBF measurements because they indicate the adequacy of CBF relative to cerebral metabolic requirements. If the brain is hypoperfused, O 2 extraction will be increased, and SjvO 2 will be reduced. Intracranial hypertension was the most common cause of jugular venous desaturation reported in a prospective study of 116 patients with severe head injury, 7 accounting for 44% of the total number of episodes. If CBF is appropriate for the brain's metabolic requirement, then SjvO 2 will be normal. Often this information is more clinically useful than the absolute CBF values.
The major limitation of using SjvO 2 as a monitor of CBF adequacy is that regional ischemia will not be identified. In conditions such as TBI, in which regional differences in CBF may occur, monitoring of brain tissue PO 2 may have an important advantage. found that the likelihood of death following a severe head injury increased with increasing duration of time that brain tissue PO 2 was below 15 mm Hg and with any occurrence of a brain tissue PO 2 less than 6 mm Hg. Kiening, et al., 11 correlated serial measurements of both SjvO 2 and brain tissue PO 2 and found that an SjvO 2 of 50% in general correlates with a brain tissue PO 2 of 8.5 mm Hg.
Recommended Monitoring Strategy
It is clear from the descriptions of the available devices that none is ideal in the setting of TBI. No single monitor continuously provides high-resolution rCBF data. At present, a reasonable strategy is to obtain intermittent measurements of rCBF, preferably by performing stable Xeenhanced CT scanning, to determine whether regional abnormalities of flow exist. If no hypoperfused regions are detected, then a global monitor, such as an SjvO 2 catheter, should suffice. If significant regional heterogeneity of flow is detected, then brain tissue PO 2 monitoring or a local CBF probe may be used as a local monitor near the hypoperfused area. This local monitor would be used in addition to a global monitor, such as an SjvO 2 catheter (Fig. 1) , which would still be needed because secondary ischemic insults are often global and usually transient. Finally, common systemic sources of secondary insults, such as blood pressure and oxygenation, should also be monitored.
CONCLUSIONS
Despite widespread recognition that systemic hypotension and intracranial hypertension are detrimental to the injured brain, the optimal CPP in patients with severe TBI and the relative importance of systemic blood pressure and ICP in contributing to optimal CPP remain debated. The normal pattern of CBF after brain injury is one of significant evolution over time. Furthermore, CBF may also vary markedly from patient to patient. For these reasons, consideration should be given to maintaining an optimal CPP in an individual patient at each specific moment in time, rather than having some arbitrary goal generalized in all patients. Monitoring of ICP together with continuous assessment of the adequacy of CBF by means of jugular venous oximetry and brain tissue PO 2 monitoring are major components of CPP optimization.
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